CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

12 hedge funds and large institutions have $95.7K invested in COSCIENS Biopharma Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

92% less call options, than puts

Call options by funds: $35K | Put options by funds: $412K

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35K
Puts
$412K
Net Calls
Net Calls Change

Top Buyers

1
+$29.9K
2
+$18.6K
3
+$59

Top Sellers

1
-$29.8K
2
-$5.92K
3
-$4.04K
4
TRCT
Tower Research Capital (TRC)
New York
-$258
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$226
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$59.8K
2
$18.6K
3
$7.44K
4
$5.58K
5
$1.23K
6
$1K
7
$582
8
$573
9
$372
10
$193
11
$164
12
$112
13
$2
14
$2
15
–
16
–